D35.0
Benign neoplasm of adrenal gland
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign neoplasm of the adrenal gland, classified under ICD-10 code D35.0, refers to a non-cancerous growth that develops in the adrenal glands. These small, often slow-growing tumors are usually not malignant and typically do not spread to other parts of the body. The adrenal glands, located atop each kidney, produce vital hormones including adrenaline, cortisol, and aldosterone. While many benign tumors are discovered incidentally during medical imaging for other conditions, understanding their nature is essential for proper management and monitoring.
Causes & Symptoms
Clinical Causes: Genetic factors that predispose individuals to tumor growth Genetic syndromes such as Multiple Endocrine Neoplasia (MEN) or Li-Fraumeni syndrome Exposure to certain environmental toxins or chemicals Age-related cellular changes, especially in middle-aged or older adults Unknown factors, as the exact cause of many benign adrenal tumors remains unclear
Key Symptoms: Most benign adrenal tumors are asymptomatic and are often found incidentally during imaging tests Hormonal imbalances leading to symptoms such as high blood pressure, excess hair growth, or skin changes, if the tumor produces hormones Potential signs of hormonal excess include weight gain, muscle weakness, or irregular heartbeat In some cases, a large tumor can cause localized pain or discomfort in the abdomen or flank area Rarely, tumors may cause hormone deficiency symptoms if they impair normal adrenal function
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically starts with imaging studies such as CT scans or MRIs, which can identify the size and location of the tumor. Blood and urine tests are used to assess hormone levels and determine if the tumor is secreting excess hormones. In certain cases, additional tests like adrenal venous sampling or histopathological examination after a biopsy may be performed to confirm the benign nature of the growth and rule out malignancy. The process aims to differentiate benign neoplasms from potentially malignant tumors and guide appropriate management.
Treatment Protocols: Treatment options depend on the size of the tumor, its hormonal activity, and the presence of symptoms. Many benign adrenal tumors that do not produce hormones and are small in size are monitored regularly with imaging and clinical assessments. Surgical removal, known as adrenalectomy, may be recommended if the tumor is large, causes hormonal imbalance, or shows signs of growth. Minimally invasive laparoscopic surgery is often preferred for suitable candidates. Post-treatment monitoring includes follow-up imaging and endocrine evaluations to ensure complete removal and assess adrenal function. In cases where the tumor is inactive and small, active surveillance may be sufficient to prevent unnecessary interventions.
Clinical Advice & FAQs
Billing Guidance
Is D35.0 a billable ICD-10 code?
Yes, D35.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D35.0?
Clinical documentation must specify the nature of Benign neoplasm of adrenal gland and any associated comorbidities for accurate reporting.
Cite this Clinical Reference